W

Women's Health Advantage | Fort Wayne, IN

Research site
(Unclaimed)
Location
2518 East Dupont Road, Fort Wayne, Indiana, United States of America
Site insights

Top conditions

Prolapse (3 trials)

Pelvic Organ Prolapse (3 trials)

Endometriosis (3 trials)

Menorrhagia (3 trials)

Enuresis (2 trials)

Top treatments

Elagolix
Norethindrone Acetate
Estradiol
LevoCept
VeraCept

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 19
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Evaluation of Efficacy, Safety and Tolerability of VeraCept IUD

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting
Women at Risk for Pregnancy
Drug: VeraCept

To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept

Begins enrollment in 8 months
Contraception
Women at Risk for Pregnancy
Drug: LevoCept

The trial objectives include evaluating the adequacy of proposed mitigations for the previous pivotal trial of the FemBloc Permanent Contraceptive Sy...

Active, not recruiting
Contraception
Device: FemBloc

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterili...

Active, not recruiting
Contraception
Device: FemBloc
Procedure: Laparoscopic bilateral tubal sterilization

This is phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menst...

Active, not recruiting
Uterine Fibroids
Heavy Menstrual Bleeding
Other: E2/NETA Placebo
Drug: E2/NETA

Prospective, multi-center, single-arm, seamless phase-pivotal study conducted in participants diagnosed with UUI who have failed or could not tolerat...

Active, not recruiting
Urinary Urgency Incontinence
Device: Neuspera Implantable Sacral Nerve Stimulation System

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling
Endometriosis
Drug: Placebo
Drug: Combined Oral Contraceptive

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic...

Active, not recruiting
Contraception
Device: ESSURE (BAY1454032)
Procedure: Laparoscopic tubal sterilization

Trial sponsors

AbbVie logo

AbbVie (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems